MedDataX Logo

OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study

NCT ID: NCT03386994

Last Updated: 2020-11-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

204 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-29

Study Completion Date

2019-09-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Descriptive prospective non-interventional multicenter study based on newly collected data of Idiopathic Pulmonary Fibrosis patients followed-up for one year in secondary care settings (Pulmonology Services)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Pulmonary Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Idiopathic Pulmonary Fibrosis patients

all IPF patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female and male patients ≥ 40 years of age
* Patients diagnosed with Idiopathic Pulmonary Fibrosis (IPF) according to last ATS/ERS/JRS/ALAT IPF guideline for diagnosis and management consensus
* Written informed consent prior to participation

Exclusion Criteria

* Inability for the patient to understand or complete the written Inform Consent or patients questionnaires or to understand Spanish
* Current participation in any clinical trial
* Patients for whom further follow-up is not possible at the enrolling site
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mireia Canals, +34607550925

Role: STUDY_CHAIR

[email protected]

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital General Universitario de Alicante

Alicante, , Spain

Site Status

Hospital Infanta Cristina

Badajoz, , Spain

Site Status

Hospital Universitario Cruces

Barakaldo (Vizcaya), , Spain

Site Status

H. del Mar

Barcelona, , Spain

Site Status

H. U. Vall d'Hebron

Barcelona, , Spain

Site Status

H. U. de Bellvitge

Barcelona, , Spain

Site Status

H. U. Germans Trias i Pujol

Barcelona, , Spain

Site Status

Hospital Universitario de Burgos

Burgos, , Spain

Site Status

Hospital General Universitario Santa Lucía

Cartagena (Murcia), , Spain

Site Status

Hospital General Universitario de Castellón

Castellon, , Spain

Site Status

H. U. de Girona Doctor Josep Trueta

Girona, , Spain

Site Status

Hospital Universitario Virgen de las Nieves

Granada, , Spain

Site Status

Can Misses

Ibiza Town, , Spain

Site Status

Hospital Universitario Lucus Augusti

Lugo, , Spain

Site Status

H. Clínico San Carlos

Madrid, , Spain

Site Status

Hospital Universitario Fundación Jiménez Díaz

Madrid, , Spain

Site Status

Hospital Universitario Puerta de Hierro

Majadahonda (Madrid), , Spain

Site Status

H. Son Llatzer

Mallorca, , Spain

Site Status

H. de Manacor

Mallorca, , Spain

Site Status

Hospital Costa del Sol

Marbella (Málaga), , Spain

Site Status

Hospital Regional Universitario de Málaga

Málaga, , Spain

Site Status

H. Mateu Orfila

Menorca, , Spain

Site Status

Hospital Montecelo

Mourente (Pontevedra), , Spain

Site Status

CHU de Ourense

Ourense, , Spain

Site Status

H. Central de Asturias

Oviedo, , Spain

Site Status

Hospital Universitari Son Espases

Palma de Mallorca, , Spain

Site Status

Hospital Universitario Donostia

San Sebastián, , Spain

Site Status

Complejo Hospitalario Universitario de Santiago

Santiago de Compostela, , Spain

Site Status

Hospital Sierrallana y Tres Mares

Torrelavega (Cantabria), , Spain

Site Status

Hospital Clínico Universitario de Valladolid

Valladolid, , Spain

Site Status

Hospital Miguel Servet

Zaragoza, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1199-0296

Identifier Type: -

Identifier Source: org_study_id